Skip to main content
ENBIOCO., LTD. logo

ENBIOCO., LTD. — Investor Relations & Filings

Ticker · 352940 ISIN · KR7352940001 KO Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 157 across all filing types
Latest filing 2020-11-30 Capital/Financing Update
Country KR South Korea
Listing KO 352940

About ENBIOCO., LTD.

http://www.enbiotech.kr/index_en.html

ENBIOCO., LTD. is a technology company specializing in sustainable wastewater treatment and water recycling solutions. The company's core offering is its 'ZERO TECHNOLOGY,' a system designed to convert various types of wastewater into clean, reusable water. Its product line includes the 'ZERO TOILET,' a self-recycling flush toilet that operates without an external water supply or discharge connection, and the 'ZERO HOUSE,' a self-sufficient mobile home featuring an integrated wastewater recycling system. The company also develops specialized applications, such as the 'LIVESTOCK WASTEWATER ZERO SYSTEM' for pig farms and mobile treatment units for industrial and lifestyle wastewater. These solutions are engineered to provide green, self-sustaining water management.

Recent filings

Filing Released Lang Actions
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '정정신고(보고)' (Amendment Report) for an '투자설명서' (Prospectus) filed by Inbio Co., Ltd. It details the finalization of the public offering price (5,800 KRW) following a demand forecast. In the context of financial filings, a prospectus (including amendments regarding pricing) is classified as a Proxy Solicitation & Information Statement (PSI) or a regulatory filing related to securities issuance. Given the specific options provided, 'PSI' is the most appropriate category for a document intended to provide information to potential investors for a public offering.
2020-11-30 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고서' (Amendment to Securities Registration Statement) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the public offering price (공모가액 확정) for Enbio Co., Ltd. and provides a comparison table of the changes made to the original filing. This type of regulatory filing for securities issuance and price determination falls under the 'Regulatory Filings' category as it is a formal legal document submitted to a regulatory body regarding capital market activities.
2020-11-30 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) for Inbio Co., Ltd., detailing a public offering of 1,630,000 shares for a KOSDAQ listing. It includes sections on investment risks, offering terms, and underwriting details. In the context of financial filings, a prospectus for an IPO or public offering is classified as a 'POS' (Registration Statement/Prospectus) or 'SHA' (Share Issue). Given the specific nature of the document as a formal prospectus for a new share issuance and listing, it aligns best with the 'SHA' (Share Issue/Capital Change) category.
2020-11-23 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Supervisory Service (DART) in South Korea. It explicitly mentions '정정신고(보고)' (Amendment Report) and provides detailed information regarding the issuance of securities, investment risks, and use of proceeds. This type of document is a formal regulatory filing required for public offerings and does not fit into the other specific categories like 10-K or Earnings Release. Therefore, it is classified as a Regulatory Filing.
2020-11-11 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details the public offering of shares for 'Enbio Co., Ltd.' (인바이오 주식회사) for the purpose of a KOSDAQ listing. It contains comprehensive information regarding the offering, investment risks, and financial details, which is characteristic of a formal securities registration filing required for an IPO.
2020-10-30 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for Inbio Co., Ltd. It includes the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes to the financial statements for the fiscal year ending December 31, 2019. Since it contains the full audited financial statements and the auditor's opinion, it is classified as an Audit Report (AR). FY 2019
2020-04-09 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.